Untitled Letters Regarding Advertising & Promotional Labeling for Approved Biologics

Untitled Letters Regarding Advertising & Promotional Labeling for Approved Biologics prior to 2017 are available on FDA Archive.

2026

• March 9, 2026 Untitled Letter - AMTAGVI
  Iovance Biotherapeutics
• March 9, 2026 Untitled Letter - BREYANZI
  Juno Therapeutics Inc., a Bristol-Myers Squibb Company
• March 9, 2026 Untitled Letter - KYMRIAH
  Novartis Pharmaceuticals Corporation
• March 9, 2026 Untitled Letter - TECARTUS
  Kite Pharma, Inc.

2025

• September 9, 2025 Untitled Letter - FLUMIST
  AstraZeneca Pharmaceuticals LP

2018

• February 27, 2018 Untitled Letter - IDELVION
  CSL Behring LLC